Stockscreener 앱 받기
16.95
0.94%
-0.16
전일 마감가:
$17.11
열려 있는:
$17.17
하루 거래량:
174.13K
Relative Volume:
0.51
시가총액:
$307.37M
수익:
$1.93M
순이익/손실:
$-7.96M
주가수익비율:
-0.0048
EPS:
-3530.8178
순현금흐름:
$-36.78M
1주 성능:
-0.41%
1개월 성능:
-11.90%
6개월 성능:
+242.42%
1년 성능:
+141.11%
1일 변동 폭
$16.79
$17.23
1주일 범위
$15.19
$17.72
52주 변동 폭
$3.39
$20.72
아발로 테라퓨틱스 Stock (AVTX) Company Profile
명칭
Avalo Therapeutics Inc
전화
410-522-8707
주소
1500 LIBERTY RIDGE DRIVE, WAYNE
AVTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
16.95 | 310.27M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
아발로 테라퓨틱스 Stock (AVTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-18 | 개시 | Mizuho | Outperform |
| 2025-09-17 | 재확인 | H.C. Wainwright | Buy |
| 2025-09-05 | 개시 | TD Cowen | Buy |
| 2025-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2025-03-25 | 개시 | Jefferies | Buy |
| 2025-03-25 | 개시 | Stifel | Buy |
| 2025-02-28 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | Wedbush | Outperform |
| 2024-12-19 | 개시 | BTIG Research | Buy |
| 2024-10-24 | 개시 | H.C. Wainwright | Neutral |
| 2024-04-16 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2021-09-24 | 개시 | RBC Capital Mkts | Outperform |
모두보기
아발로 테라퓨틱스 주식(AVTX)의 최신 뉴스
Insider Sell: Is Avalo Therapeutics Inc stock positioned for digital transformationJuly 2025 Technicals & AI Optimized Trading Strategy Guides - moha.gov.vn
Will Avalo Therapeutics Inc. stock benefit from AI adoptionJuly 2025 Retail & Step-by-Step Trade Execution Guides - ulpravda.ru
Will Avalo Therapeutics Inc. stock split attract more investorsEarnings Overview Summary & Risk Controlled Swing Alerts - ulpravda.ru
Moving Averages: Will Avalo Therapeutics Inc. stock split attract more investorsWall Street Watch & Safe Entry Trade Signal Reports - ulpravda.ru
Is Avalo Therapeutics Inc. stock positioned well for digital economy2025 Risk Factors & High Accuracy Swing Trade Signals - ulpravda.ru
Avalo Therapeutics Reports Q3 2025 Financial Results - MSN
Avalo Therapeutics Files $750 Million Mixed Shelf - MarketScreener
What margin trends mean for Avalo Therapeutics Inc. stockSwing Trade & Technical Pattern Based Signals - ulpravda.ru
Aug Momentum: Will Avalo Therapeutics Inc. stock benefit from AI adoptionAnalyst Downgrade & Accurate Intraday Trading Signals - ulpravda.ru
Is Avalo Therapeutics Inc. stock attractive after correctionPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Why analysts remain bullish on Avalo Therapeutics Inc. stockSwing Trade & Fast Gaining Stock Strategy Reports - ulpravda.ru
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
How rising interest rates impact Avalo Therapeutics Inc. stock2025 Trading Recap & Capital Protection Trade Alerts - DonanımHaber
Avalo Therapeutics (NASDAQ:AVTX) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat
Will Avalo Therapeutics Inc. (C6K0) stock announce special dividend2025 Market Outlook & Fast Moving Stock Trade Plans - DonanımHaber
Can Avalo Therapeutics Inc. (C6K0) stock survive global slowdownWeekly Stock Summary & Fast Entry Momentum Alerts - DonanımHaber
Breakout Move: Is Avalo Therapeutics Inc. stock a buy on dipsJuly 2025 Macro Moves & Precise Swing Trade Alerts - Улправда
This Valvoline Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Mizuho Initiates Coverage of Avalo Therapeutics (AVTX) with Outperform Recommendation - Nasdaq
Mizuho Initiates Avalo Therapeutics at Outperform With $39 Price Target - marketscreener.com
AVTX: Mizuho Initiates Coverage with Outperform Rating and $39 P - GuruFocus
Mizuho initiates Avalo Therapeutics stock with Outperform rating on HS drug potential By Investing.com - Investing.com South Africa
Mizuho initiates Avalo Therapeutics stock with Outperform rating on HS drug potential - Investing.com Canada
AVTX FinancialsIncome Statement - Quiver Quantitative
EBITDA per share of Avalo Therapeutics Inc – FWB:C6K0 - TradingView — Track All Markets
Avalo Therapeutics Earnings Notes - Trefis
Forecast Cut: How Avalo Therapeutics Inc stock valuations compare to rivalsEarnings Summary Report & Risk Controlled Swing Alerts - moha.gov.vn
Officer Riley Surrenders 637 Of Avalo Therapeutics Inc [AVTX] - TradingView — Track All Markets
Avalo Therapeutics (AVTX) officer discloses employee share transaction details - Stock Titan
Its Stock Has Paid Off Big Time For Avalo Therapeutics Inc - Setenews
With Avalo Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Why analysts maintain buy rating on Avalo Therapeutics Inc. (C6K0) stockWeekly Risk Report & Reliable Intraday Trade Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock could be next leaderGlobal Markets & Expert Curated Trade Setup Alerts - Newser
Why Avalo Therapeutics Inc. (C6K0) stock stays resilient2025 Support & Resistance & Risk Managed Investment Strategies - Newser
How buybacks impact Avalo Therapeutics Inc. stock value2025 Winners & Losers & Low Risk Investment Opportunities - Newser
Financial Comparison: InMed Pharmaceuticals (NASDAQ:INM) & Avalo Therapeutics (NASDAQ:AVTX) - Defense World
What hedge fund activity signals for Avalo Therapeutics Inc. stockDip Buying & Low Drawdown Trading Techniques - Newser
Is Avalo Therapeutics Inc. (C6K0) stock a top dividend aristocrat candidateNew Guidance & Safe Entry Momentum Tips - Newser
Published on: 2025-12-03 02:49:42 - Newser
Is Avalo Therapeutics Inc. (C6K0) stock overpriced at current multiplesWeekly Market Summary & Low Drawdown Investment Ideas - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives $31.67 Average PT from Analysts - Defense World
Taking the lead: Avalo Therapeutics Inc (AVTX) - setenews.com
How Avalo Therapeutics Inc. stock benefits from strong dollarTrade Exit Summary & AI Based Buy and Sell Signals - Newser
Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView — Track All Markets
Is Avalo Therapeutics Inc. (C6K0) stock resilient in recession scenariosWeekly Risk Summary & Smart Allocation Stock Reports - Newser
What is the fair value of Avalo Therapeutics Inc. stock nowInflation Watch & Risk Controlled Stock Pick Alerts - Newser
How Avalo Therapeutics Inc. (C6K0) stock performs in easing cyclesGap Up & Community Consensus Trade Alerts - Newser
Avalo Therapeutics, Inc. (NASDAQ:AVTX) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
HC Wainwright Has Bearish Estimate for AVTX FY2025 Earnings - Defense World
아발로 테라퓨틱스 (AVTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.90%
자본화:
|
볼륨(24시간):